Bacterial Cell Banking
Media optimization
Fermentation development and production, anaerobic and aerobic, flask to 100 liter scale
Downstream purification development and production
Formulation, aseptic filling and lyophilization |
Bacterial Toxins
Phase I – III clinical trial material
Lipopolysaccharides (LPS)
Toxoids
Toxin Conjugates
FRET Peptides
Toxin antibodies |
cGMP Compliant
Select Agent approved to BSL3 large scale
Facility designed for product segregation and spore containment
California Drug Manufacturing License |